Research

EngagedMD Reduces Anxiety in Infertility Patients

Introduction

Infertility and the associated treatments can be a source of anxiety for many patients. To address this issue, a recent study investigated the impact of EngagedMD’s e-learning platform on patients' anxiety levels during infertility treatment cycles.

The study was a prospective randomized controlled trial that included patients aged 18-43 years who were undergoing their first intrauterine insemination (IUI) or in-vitro fertilization (IVF) cycle. The patients were randomized into two groups: the conventional group, which received standard fertility counseling from their physician and nurse team, and the EngagedMD (EMD) group, which received standard counseling plus access to EngagedMD’s e-learning platform.

The patients completed surveys at three time points to assess their anxiety levels: prior to treatment (T1), after the MD/RN teaching session at the start of their cycle (T2), and after cycle completion (T3). The surveys included a modified 19-question State-Trait Anxiety Inventory (STAI) to quantitatively assess the patients' anxiety levels.

Results

The results of the study showed that access to the EngagedMD platform significantly reduced anxiety levels in patients undergoing their first IUI or IVF cycle. The patients in the EMD group had lower anxiety scores at T2 and T3 compared to the conventional group. Additionally, the patients in the conventional group had a significant decrease in their anxiety levels from T1 to T2 and T1 to T3, while the patients in the EMD group had no significant change in their anxiety levels throughout the treatment cycle.

The study has important implications for the use of e-learning platforms in healthcare. The EngagedMD platform was effective in reducing anxiety levels in patients undergoing infertility treatments, which suggests that similar platforms could be used to address anxiety in other healthcare contexts. The platform is also user-friendly and accessible, which makes it a promising tool for improving patient education and engagement.

Conclusion

In conclusion, the use of EngagedMD’s e-learning platform was found to significantly reduce anxiety levels in patients undergoing their first IUI or IVF cycle. The platform is user-friendly and accessible, which makes it a promising tool for improving patient education and engagement in healthcare

EngagedMD Reduces Anxiety in Infertility Patients

EngagedMD Reduces Anxiety in Infertility Patients

Introduction

Infertility and the associated treatments can be a source of anxiety for many patients. To address this issue, a recent study investigated the impact of EngagedMD’s e-learning platform on patients' anxiety levels during infertility treatment cycles.

The study was a prospective randomized controlled trial that included patients aged 18-43 years who were undergoing their first intrauterine insemination (IUI) or in-vitro fertilization (IVF) cycle. The patients were randomized into two groups: the conventional group, which received standard fertility counseling from their physician and nurse team, and the EngagedMD (EMD) group, which received standard counseling plus access to EngagedMD’s e-learning platform.

The patients completed surveys at three time points to assess their anxiety levels: prior to treatment (T1), after the MD/RN teaching session at the start of their cycle (T2), and after cycle completion (T3). The surveys included a modified 19-question State-Trait Anxiety Inventory (STAI) to quantitatively assess the patients' anxiety levels.

Results

The results of the study showed that access to the EngagedMD platform significantly reduced anxiety levels in patients undergoing their first IUI or IVF cycle. The patients in the EMD group had lower anxiety scores at T2 and T3 compared to the conventional group. Additionally, the patients in the conventional group had a significant decrease in their anxiety levels from T1 to T2 and T1 to T3, while the patients in the EMD group had no significant change in their anxiety levels throughout the treatment cycle.

The study has important implications for the use of e-learning platforms in healthcare. The EngagedMD platform was effective in reducing anxiety levels in patients undergoing infertility treatments, which suggests that similar platforms could be used to address anxiety in other healthcare contexts. The platform is also user-friendly and accessible, which makes it a promising tool for improving patient education and engagement.

Conclusion

In conclusion, the use of EngagedMD’s e-learning platform was found to significantly reduce anxiety levels in patients undergoing their first IUI or IVF cycle. The platform is user-friendly and accessible, which makes it a promising tool for improving patient education and engagement in healthcare